A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Clinical trial NCT06238479 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06238479
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor Recurrent Solid Tumor Advanced Solid Tumor Urinary Bladder Neoplasm Triple Negative Breast Cancer Non-small Cell Lung Cancer Esophageal Cancer Pancreatic Cancer Ovarian Cancer Cervical Cancer Head and Neck Squamous Cell Carcinoma Prostate Cancer

Start date: 2024-03-05
Primary completion: 2027-03-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.